Study Detail

TitleAllogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing
Study TypeOther
Abstract In patients with acute myeloid leukemia (AML) consolidation treatment options are between allogeneic hematopoietic stem cell transplantation (HCT) and chemotherapy, based on disease risk at the time of initial presentation and age. Depth of remission following induction chemotherapy is not taken int .. [more]
Description In patients with acute myeloid leukemia (AML) consolidation treatment options are between allogeneic hematopoietic stem cell transplantation (HCT) and chemotherapy, based on disease risk at the time of initial presentation and age. Depth of remission following induction chemotherapy is not taken int .. [more]
Center NameCHONNAM NATIONAL UNIVERSITY